Metformin use linked to reduced risk of myeloproliferative n

Metformin use linked to reduced risk of myeloproliferative neoplasms

People who use metformin are less likely to develop a myeloproliferative neoplasm (MPN) over time, indicating that the treatment may help prevent the development of certain types of cancers, according to a study published in Blood Advances.

Related Keywords

Denmark , Stidsholt , Nordjylland , United States , Aalborg , American , Danish , Daniel Tuyet Kristensen , Aalborg University Hospital , Aarhus University Hospital , American Society Of Hematology , Stidsholt Roug ,

© 2025 Vimarsana